FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/26/2022
Back to search
Official data from USPTO
ZELLBRIDGE VANDEFITEMCEL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
09/26/2022
Classification
Registered
Trademark type
Combined
Nice classes
5, 10
Filing date
08/03/2020
Registration date
05/03/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/03/2022
Last transaction
05/03/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
JP
Examiner
CIANCI, RYAN
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of two teal lines, a purple line, and a purple circle forming a silhouette of a person. Below the person, the purple wording "ZELLBRIDGE" appears above the teal wording "VANDEFITEMCEL". The white background is not claimed as a feature of the mark.
Holders and representatives
Holders
SanBio Company Limited
Representatives
N. Alexander Nolte Nolte Lackenbach Siegel
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Stem cells for medical and veterinary purposes; pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of traumatic brain injury, cerebral infarction, cerebral hemorrhage, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury, and Alzheimer's disease; all the aforementioned being vandefitemcel that are stem cells affecting fibroblasts for use during cell therapy
Class 10
Apparatus for the regeneration of stem cells for medical purposes; medical apparatus and instruments used for cell culture, namely, for cell culture chambers; medical apparatus and instruments, namely, cell testing apparatus in the nature of medical diagnostic apparatus for testing cancer cells, DNA, blood cells and extra cellular contents; medical apparatus and instruments, namely, intracellular material injector for medical purposes in the nature of injection instrument with needles, needle-based and needle-free injection systems; medical apparatus and instruments for monitoring vital signs, for use in orthopedic surgery; medical apparatus and instruments for analyzing substances for medical purposes, namely, blood and cell analyzers for medical diagnostics; medical apparatus and instruments, namely, test tubes for cell separation for medical purposes in the nature of blood testing apparatus, namely, blood sampling tubes; medical apparatus and instruments, namely, apparatus for the regeneration of stem cells for medical purposes; gene and genetic testing apparatus in the nature of apparatus for DNA and RNA testing for medical purposes; medical apparatus and instruments, namely, cell injector for medical purposes in the nature of injection instrument with needles; medical apparatus and instruments, namely, needle-based and needle-free injection systems; implants consisting of artificial materials; artificial implants in the nature of surgical implants comprised of artificial materials and artificial vascular grafts
Publications
History of USPTO decisions and trademark events.
36 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/02/2022
FIMP
FINAL DISPOSITION PROCESSED
09/02/2022
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
09/02/2022
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
08/15/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/03/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
05/03/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/26/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/09/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/09/2022
GPNX
NOTIFICATION PROCESSED BY IB
02/20/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/15/2022
PUBO
PUBLISHED FOR OPPOSITION
02/15/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/26/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/26/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/26/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/07/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/05/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/05/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/05/2022
RFNP
REFUSAL PROCESSED BY IB
08/15/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/12/2021
GNRT
NON-FINAL ACTION E-MAILED
07/12/2021
CNRT
NON-FINAL ACTION WRITTEN
07/12/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/16/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/16/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/16/2021
RFNT
REFUSAL PROCESSED BY IB
01/04/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/16/2020
RFRR
REFUSAL PROCESSED BY MPU
12/16/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/03/2020
CNRT
NON-FINAL ACTION WRITTEN
12/02/2020
DOCK
ASSIGNED TO EXAMINER
11/24/2020
MAFR
APPLICATION FILING RECEIPT MAILED
10/17/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/13/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/08/2020
Continuous trademark protection
Get notified about every new filing that threatens ZELLBRIDGE VANDEFITEMCEL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.